Products that we parallel export to all Europe are branded products with the same formulation, active ingredients, and therapeutic effects of the correspondent branded products already marketed in Greece.
The National Medicines Agency of Greece (EOF), if necessary, releases to Exelixis a license for each drug to be exported to any EU member state.
Exelixis requires high qualitative standards to parallel export products, by using box, labels, packing material and temperature control procedures and materials made by companies leader in pharmaceutical sector.
All packaging activities are performed to make the exported product completely safe.